Literature DB >> 33503881

Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine-Glutamate Cycle.

Nikhil R Gandasi1, Vasiliki Arapi2, Michel E Mickael3,4, Prajakta A Belekar1, Louise Granlund2, Lakshmi Kothegala1, Robert Fredriksson2, Sonchita Bagchi2.   

Abstract

SLC38A6 (SNAT6) is the only known member of the SLC38 family that is expressed exclusively in the excitatory neurons of the brain. It has been described as an orphan transporter with an unknown substrate profile, therefore very little is known about SNAT6. In this study, we addressed the substrate specificity, mechanisms for internalization of SNAT6, and the regulatory role of SNAT6 with specific insights into the glutamate-glutamine cycle. We used tritium-labeled amino acids in order to demonstrate that SNAT6 is functioning as a glutamine and glutamate transporter. SNAT6 revealed seven predicted transmembrane segments in a homology model and was localized to caveolin rich sites at the plasma membrane. SNAT6 has high degree of specificity for glutamine and glutamate. Presence of these substrates enables formation of SNAT6-caveolin complexes that aids in sodium dependent trafficking of SNAT6 off the plasma membrane. To further understand its mode of action, several potential interacting partners of SNAT6 were identified using bioinformatics. Among them where CTP synthase 2 (CTPs2), phosphate activated glutaminase (Pag), and glutamate metabotropic receptor 2 (Grm2). Co-expression analysis, immunolabeling with co-localization analysis and proximity ligation assays of these three proteins with SNAT6 were performed to investigate possible interactions. SNAT6 can cycle between cytoplasm and plasma membrane depending on availability of substrates and interact with Pag, synaptophysin, CTPs2, and Grm2. Our data suggest a potential role of SNAT6 in glutamine uptake at the pre-synaptic terminal of excitatory neurons. We propose here a mechanistic model of SNAT6 trafficking that once internalized influences the glutamate-glutamine cycle in presence of its potential interacting partners.

Entities:  

Keywords:  Na+-dependent transporter; SNAT6; caveolin; endocytosis; excitatory neurons; glutamate–glutamine cycle; pre-synaptic terminal; solute carrier proteins

Mesh:

Substances:

Year:  2021        PMID: 33503881      PMCID: PMC7865731          DOI: 10.3390/ijms22031167

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  60 in total

1.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

2.  Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole.

Authors:  Jeffrey D Erickson
Journal:  J Neurochem       Date:  2017-05-18       Impact factor: 5.372

Review 3.  Profiling of astrocyte properties in the hyperammonaemic brain: shedding new light on the pathophysiology of the brain damage in hyperammonaemia.

Authors:  U Lichter-Konecki
Journal:  J Inherit Metab Dis       Date:  2008-08-09       Impact factor: 4.982

4.  A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis.

Authors:  Marcus J Taylor; David Perrais; Christien J Merrifield
Journal:  PLoS Biol       Date:  2011-03-22       Impact factor: 8.029

5.  ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context.

Authors:  Adam A Margolin; Ilya Nemenman; Katia Basso; Chris Wiggins; Gustavo Stolovitzky; Riccardo Dalla Favera; Andrea Califano
Journal:  BMC Bioinformatics       Date:  2006-03-20       Impact factor: 3.169

6.  Histological analysis of SLC38A6 (SNAT6) expression in mouse brain shows selective expression in excitatory neurons with high expression in the synapses.

Authors:  Sonchita Bagchi; Hajar Ali Baomar; Somar Al-Walai; Saifaddin Al-Sadi; Robert Fredriksson
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

7.  Improved Methods for Fluorescence Microscopy Detection of Macromolecules at the Axon Initial Segment.

Authors:  Musaad A Alshammari; Tahani K Alshammari; Fernanda Laezza
Journal:  Front Cell Neurosci       Date:  2016-02-16       Impact factor: 5.505

8.  The gene expression of numerous SLC transporters is altered in the immortalized hypothalamic cell line N25/2 following amino acid starvation.

Authors:  Sofie V Hellsten; Emilia Lekholm; Tauseef Ahmad; Robert Fredriksson
Journal:  FEBS Open Bio       Date:  2017-01-11       Impact factor: 2.693

9.  Role of Metabotropic Glutamate Receptors in Neurological Disorders.

Authors:  Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea
Journal:  Front Mol Neurosci       Date:  2019-02-08       Impact factor: 5.639

10.  Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin.

Authors:  Markus Sällman Almén; Karl J V Nordström; Robert Fredriksson; Helgi B Schiöth
Journal:  BMC Biol       Date:  2009-08-13       Impact factor: 7.431

View more
  4 in total

1.  SLC38A10 Knockout Mice Display a Decreased Body Weight and an Increased Risk-Taking Behavior in the Open Field Test.

Authors:  Frida A Lindberg; Karin Nordenankar; Robert Fredriksson
Journal:  Front Behav Neurosci       Date:  2022-05-23       Impact factor: 3.617

2.  SLC38A10 Regulate Glutamate Homeostasis and Modulate the AKT/TSC2/mTOR Pathway in Mouse Primary Cortex Cells.

Authors:  Rekha Tripathi; Tanya Aggarwal; Frida A Lindberg; Anna H Klemm; Robert Fredriksson
Journal:  Front Cell Dev Biol       Date:  2022-04-05

3.  Circ_0110940 Exerts an Antiapoptotic and Pro-Proliferative Effect in Gastric Cancer Cells via the miR-1178-3p/SLC38A6 Axis.

Authors:  Xiaonan Miao; Haiou Zou; Lijuan Pan; Jing Cheng; Youshan Wu; Rui Chen; Yong Su; Hongwei Du
Journal:  J Oncol       Date:  2022-06-30       Impact factor: 4.501

Review 4.  Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Authors:  Johanna Huttunen; Santosh Kumar Adla; Magdalena Markowicz-Piasecka; Kristiina M Huttunen
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.